It all starts with a patient
Global Liver Institute saves lives by empowering patient advocates to collaborate with policymakers, clinicians, and industry to drive the liver health field forward.
How we’re making a difference.
Dr. Katelin H.
“There is nothing more powerful than sharing your story with others, whether with your own family or with the whole country. You’d be surprised how much impact simple actions can have.
Improving the lives of individuals & families.
Global Liver Institute (GLI) is a nonprofit organization founded in the belief that liver health must take its place on the global public health agenda commensurate with the prevalence and impact of liver illness.
GLI promotes innovation, encourages collaboration, and supports the scaling of optimal approaches to help eradicate liver diseases. Operating globally, GLI is committed to solving the problems that matter to liver patients and equipping advocates to improve the lives of individuals and families impacted by liver disease.
GLI LIVE started in March 2020, as a COVID-19 response program for liver patients. It has now evolved into a weekly educational show with tailored information for patients living with liver diseases on a variety of timely topics.
Global Liver Institute created Liver Central to equip everyone affected by liver cancer. We know that learning, advocacy, and collaboration empowers us to create change in the exam room, in the community, and beyond. Whether you have just received a liver cancer diagnosis, you are interested in new treatment options or clinical trials, or you’re a clinician looking for current practice guidelines, Liver Central exists to help you find the answers you pursue.
200 multidisciplinary stakeholders work together on our councils
With NASH drug approval in the US on the horizon, energy has been high throughout the field. Nevertheless, we still face challenges – regulatory science must be aligned, and advocacy among stakeholders must be employed to help patients understand what to expect once we enter this new stage of NASH treatments.
Obstetric and Neonatal Professionals Must Work More Closely with Pregnant People to Identify Liver Diseases Early
(Washington D.C., February 1, 2023) – Global Liver Institute (GLI) launches its third annual #RareAware campaign today to raise awareness of and build resources for liver health challenges to maternal and neonatal well-being through a series of webinars, storytimes, and social media outreach. Liver diseases such as (spell out) ICP and BA can complicate a pregnancy or endanger a newborn’s earliest days, in the worst cases threatening the lives of baby and mother alike.
Happy New Year! We hope the year has already begun to bring you fresh energy and new opportunities. Indeed, last year ended with a bang for liver health. In case you missed it, we’re here to catch you up.